United States · FDA National Drug Code directory
MYXREDLIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0338-0126_9642c441-5143-410a-af83-db5daded5420
- Product NDC
- 0338-0126
- Form
- INJECTION, SOLUTION
- Composition / generic term
- insulin human
- Labeler
- Baxter Healthcare Corporation
- Marketing category
- BLA
- Marketing start / end (source format)
- 20190712
- Source listing expiry
- 20271231
Source-listed ingredients
- INSULIN HUMAN — 1 [iU]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 12 CONTAINER in 1 CARTON (0338-0126-12) / 100 mL in 1 CONTAINER · 0338-0126-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →